BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 35008490)

  • 1. Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer.
    Luo YH; Yang YP; Chien CS; Yarmishyn AA; Adekunle Ishola A; Chien Y; Chen YM; Tsai PH; Lin TW; Wang ML; Chiou SH
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC).
    Hong W; Xue M; Jiang J; Zhang Y; Gao X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):149. PubMed ID: 32746878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.
    Lei J; Zhu J; Hui B; Jia C; Yan X; Jiang T; Wang X
    Cancer Immunol Immunother; 2023 Jan; 72(1):101-124. PubMed ID: 35750765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 6. hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.
    Li C; Zhang J; Yang X; Hu C; Chu T; Zhong R; Shen Y; Hu F; Pan F; Xu J; Lu J; Zheng X; Zhang H; Nie W; Han B; Zhang X
    Cell Death Dis; 2021 Aug; 12(9):807. PubMed ID: 34433810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis.
    Zhang N; Fan J; Deng Z
    Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.
    Jiang MM; Mai ZT; Wan SZ; Chi YM; Zhang X; Sun BH; Di QG
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):667-674. PubMed ID: 29372377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-κB pathway.
    Wu F; Sun G; Zheng W; Tang W; Cheng Y; Wu L; Li X; Tao J; Ma S; Cao H
    J Clin Lab Anal; 2021 Dec; 35(12):e24003. PubMed ID: 34676904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway.
    Xu YJ; Zhao JM; Gao C; Ni XF; Wang W; Hu WW; Wu CP
    Cell Signal; 2021 Oct; 86():110095. PubMed ID: 34320370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation.
    Miao Z; Li J; Wang Y; Shi M; Gu X; Zhang X; Wei F; Tang X; Zheng L; Xing Y
    Mol Cancer; 2023 Dec; 22(1):205. PubMed ID: 38093288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
    Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
    Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.
    Mo WL; Deng LJ; Cheng Y; Yu WJ; Yang YH; Gu WD
    Aging (Albany NY); 2021 Apr; 13(8):11629-11645. PubMed ID: 33879631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression.
    She Y; Han Y; Zhou G; Jia F; Yang T; Shen Z
    Cancer Genet; 2020 Feb; 241():12-19. PubMed ID: 31962276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.